Search research articles
Contact Us
Filters
Showing results (11-20 of 19) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 19 results.
The American Journal of Psychiatry
|
June 30, 2001
Olanzapine-induced somnambulism
T T Kolivakis, H C Margolese, L Beauclair, et al.
Journal of Clinical Psychopharmacology
|
April 1, 1994
Clonazepam in the treatment of panic disorder: a double-blind, placebo-controlled trial investigating the correlation between clonazepam concentrations in plasma and clinical response
L Beauclair, R Fontaine, L Annable, et al.
International Clinical Psychopharmacology
|
July 1, 1990
Zopiclone and triazolam in insomnia associated with generalized anxiety disorder: a placebo-controlled evaluation of efficacy and daytime anxiety
R Fontaine, P Beaudry, P Le Morvan, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
August 1, 1996
Potentiation of fluoxetine by aminoglutethimide, an adrenal steroid suppressant, in obsessive-compulsive disorder resistant to SSRIs: a case report
G Chouinard, M C Bélanger, L Beauclair, et al.
Journal of Clinical Psychopharmacology
|
August 1, 1987
An adjunctive role for ascorbic acid in the treatment of schizophrenia?
L Beauclair, S Vinogradov, S J Riney, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie
|
December 30, 1998
Phase-IV multicentre clinical study of risperidone in the treatment of outpatients with schizophrenia. The RIS-CAN-3 Study Group
G Chouinard, L Kopala, A Labelle, et al.
Journal of Clinical Psychopharmacology
|
February 1, 1993
A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients
G Chouinard, B Jones, G Remington, et al.
Journal of Psychiatry & Neuroscience : JPN
|
March 1, 1997
Moclobemide versus fluoxetine in the treatment of major depressive disorder in adults
Y D Lapierre, R Joffe, K McKenna, et al.
Journal of Affective Disorders
|
July 14, 1999
A Canadian multicenter, double-blind study of paroxetine and fluoxetine in major depressive disorder
G Chouinard, B Saxena, M C Bélanger, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 19) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 19 results.
The American Journal of Psychiatry
|
June 30, 2001
Olanzapine-induced somnambulism
T T Kolivakis, H C Margolese, L Beauclair, et al.
Journal of Clinical Psychopharmacology
|
April 1, 1994
Clonazepam in the treatment of panic disorder: a double-blind, placebo-controlled trial investigating the correlation between clonazepam concentrations in plasma and clinical response
L Beauclair, R Fontaine, L Annable, et al.
International Clinical Psychopharmacology
|
July 1, 1990
Zopiclone and triazolam in insomnia associated with generalized anxiety disorder: a placebo-controlled evaluation of efficacy and daytime anxiety
R Fontaine, P Beaudry, P Le Morvan, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
August 1, 1996
Potentiation of fluoxetine by aminoglutethimide, an adrenal steroid suppressant, in obsessive-compulsive disorder resistant to SSRIs: a case report
G Chouinard, M C Bélanger, L Beauclair, et al.
Journal of Clinical Psychopharmacology
|
August 1, 1987
An adjunctive role for ascorbic acid in the treatment of schizophrenia?
L Beauclair, S Vinogradov, S J Riney, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie
|
December 30, 1998
Phase-IV multicentre clinical study of risperidone in the treatment of outpatients with schizophrenia. The RIS-CAN-3 Study Group
G Chouinard, L Kopala, A Labelle, et al.
Journal of Clinical Psychopharmacology
|
February 1, 1993
A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients
G Chouinard, B Jones, G Remington, et al.
Journal of Psychiatry & Neuroscience : JPN
|
March 1, 1997
Moclobemide versus fluoxetine in the treatment of major depressive disorder in adults
Y D Lapierre, R Joffe, K McKenna, et al.
Journal of Affective Disorders
|
July 14, 1999
A Canadian multicenter, double-blind study of paroxetine and fluoxetine in major depressive disorder
G Chouinard, B Saxena, M C Bélanger, et al.
Page
of 2